Neuroscience

Why 'smart drugs' can make you less clever

It is an open secret: while athletes dope their bodies, regular office workers dope their brains. They buy prescription drugs such as Ritalin or Provigil on the internet's flourishing black market to boost their cognitive ...

Medications

New research predicts market share for drug makers

Lagging behind in launching new medicines means a much smaller market share for pharmaceutical companies—even if they spend just as much on advertising, according to new research from Duke University's Fuqua School of Business.

Medications

Drug sales to hit lowest growth rate in decades

Growth in global prescription drug spending will slow to the lowest rate in decades as low-cost generic drugs continue replacing former blockbusters in the U.S. and Europe, where governments face new pressure to reduce health ...

Medications

Counterfeit medicine trade targets Africa's poor

From Cameroon to Ivory Coast, Kenya to the DR Congo, traders in counterfeit drugs do a thriving business with the utmost cynicism and sometimes at the cost of human lives.

Medical research

For some men, it's 'T' time—test or no test

Prescriptions for testosterone therapy have increased significantly during the last 10 years, according to a study in the current issue of JAMA Internal Medicine conducted by researchers at the University of Texas Medical ...

Addiction

WHO urges global ban on all tobacco marketing

Governments worldwide must ban all forms of tobacco marketing, not just billboards and TV ads, as companies find new ways to tap the market, the World Health Organization said Wednesday.

Health

Unethical advertising at launch of antidepressants

The new feature of the antidepressant drugs of the 1990s was that they had milder side-effects than their predecessors. Combined with aggressive marketing, this meant that annual sales in Sweden increased from just under ...

Medications

Doctors say cancer drug costs are too high

More than 100 doctors from around the world have signed a letter decrying the high cost of cancer drugs which reach $100,000 per year or more, and calling for pharmaceutical companies to ease prices.

page 7 from 14